≡ Content Category ≡ Main Menu

Editors’ Note: The following blog post originally appeared on Forbes.com. Renewing your driver’s license at the DMV is one of those mundane chores modern life imposes on us. We wait for our number to be called, to have our eyes checked, and verify our address. Only at the last step of the process are we confronted with a Read More

Many faculty members at Albert Einstein College of Medicine and elsewhere are likely inundated with requests to contribute articles to journals—none of which they’ve ever heard of. When I started receiving such requests, I was first surprised; then I became skeptical. As the requests kept pouring in, I created a folder in my email named Read More

I was saddened to read that Ben Barres, M.D., Ph.D., had died recently. His obituary in the New York Times is worth reading. Ben was a highly respected neuroscientist and chair of the department of neurobiology at Stanford from 2008 until last year, when he got sick. But he was also a highly effective spokesperson Read More

upturned palm holding the word "gratitude"

In my family, as in many others, during the holiday season we volunteer at soup kitchens and purchase gifts to donate to children who might otherwise have none for Christmas. It’s our way of expressing our gratitude. This got me thinking about gratitude in the face of developmental disability. Daily life is often difficult for Read More

CDC Headquarters

Because I am an internal-medicine physician, friends and family members frequently ask me to recommend other physicians. When I make these endorsements, they are always of doctors who I trust will deliver the most evidence-based care. Why? Because the doctor who keeps up with the medical literature, whose practice evolves to incorporate new scientific discoveries Read More

blue capsule in woman's hand

Editors’ Note: This article originally appeared in STAT on Dec. 5, 2017. “Smart pills” that can track whether or when you’ve taken your medication might be helpful for some people. Unfortunately, the first smart pill approved by the Food and Drug Administration, Abilify MyCite, is a drug used to treat schizophrenia and bipolar disorder. That raises tricky ethical issues. Decades of Read More